Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
MGZ Medical Genetics Center | RCV002289036 | SCV002581399 | uncertain significance | Coffin-Siris syndrome 11 | 2022-03-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003101664 | SCV003680282 | uncertain significance | Inborn genetic diseases | 2021-07-09 | criteria provided, single submitter | clinical testing | The c.142C>G (p.L48V) alteration is located in exon 1 (coding exon 1) of the SMARCD1 gene. This alteration results from a C to G substitution at nucleotide position 142, causing the leucine (L) at amino acid position 48 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |